RICHARD HOPKINS: Open Payments
NPI 1881632933 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 43 payments from 14 companies in 2025. Trend: 2023 $281 · 2024 $804 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $169 |
| AstraZeneca Pharmaceuticals LP | 9 | $143 |
| Genentech USA, Inc. | 1 | $125 |
| GENZYME CORPORATION | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| CSL Behring | 2 | $52 |
| Amgen Inc. | 2 | $33 |
| Grifols USA, LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: DUPIXENT, XOLAIR, FASENRA, Hizentra, TEZSPIRE, HYQVIA, Rhapsido, EOHILIA.
Industry payments across OH — which companies pay providers there.
